Genomics

HS 16/12/2023

A federal appeals court said the U.S. government was right to challenge Illumina’s purchase of cancer-test developer Grail, but still...

HS 05/09/2023

Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight...

HS 12/06/2023

ShareListen(2 min) Source link

HS 11/06/2023

Activist investor Carl Icahn has signaled he wants former CEO Jay Flatley to return to gene-sequencing test maker. Source link

HS 03/06/2023

Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch. Source link

HS 06/09/2022

BRUSSELS—The European Union blocked Illumina Inc.’s acquisition of Grail Inc., just days after the American life-sciences company won its case...

HS 01/09/2022

An administrative law judge has ruled in favor of Illumina Inc. ILMN -2.10% in its $7.1 billion acquisition of cancer-testing...